Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting HER2 and HER3 with bispecific antibodies in cancerous cells

Targeting HER2 and HER3 with bispecific antibodies in cancerous cells

US Patent 10519247 · Granted Dec 31, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of depleting target antigen-specific antibody from a patient by administe2025
Endolysosomal targeting conjugates for improved delivery of cargo molecules to t2023
Endolysosomal targeting conjugates for improved delivery of cargo molecules to t2023
Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies 2022
Recombinant production of immunoglobulin-like domains in prokaryotic cells2000